AbCellera Biologics Inc (ABCL)
3.95
+0.11
(+2.86%)
USD |
NASDAQ |
May 09, 16:00
3.96
+0.01
(+0.25%)
Pre-Market: 08:15
AbCellera Biologics Net Income (TTM): -146.40M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -146.40M |
| September 30, 2023 | -129.14M |
| June 30, 2023 | -73.91M |
| March 31, 2023 | -50.16M |
| December 31, 2022 | 158.52M |
| September 30, 2022 | 248.36M |
| June 30, 2022 | 200.36M |
| Date | Value |
|---|---|
| March 31, 2022 | 204.82M |
| December 31, 2021 | 153.47M |
| September 30, 2021 | 210.52M |
| June 30, 2021 | 229.21M |
| March 31, 2021 | 238.23M |
| December 31, 2020 | 118.92M |
| September 30, 2020 | 0.2757M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-146.40M
Minimum
Dec 2023
248.36M
Maximum
Sep 2022
97.36M
Average
155.99M
Median
Net Income (TTM) Benchmarks
| Acasti Pharma Inc | -38.77M |
| Aurinia Pharmaceuticals Inc | -78.02M |
| Edesa Biotech Inc | -7.718M |
| Lexaria Bioscience Corp | -5.440M |
| InMed Pharmaceuticals Inc | -6.351M |